Amyris, Inc., a vertically integrated synthetic biology company and leading innovator in the field of industrial biotechnology, today announced that it has acquired Ingredion's 31% stake in ...

Amboss, a leader in AI-driven solutions for the Bitcoin Lightning Network, today unveiled Rails, a self-custodial Bitcoin ...

Halia Therapeutics is a clinical-stage biopharmaceutical company developing therapies that modulate the innate immune system to treat inflammation-driven diseases. By uncovering the biology behind ...

Cardiology Consultants of Philadelphia and Penn Medicine is among the partnership opening the $10 million project.

The current system of specialized institutes at the NIH has led to transformative breakthroughs in cancer therapies, heart ...

Oregon State University scientists have improved artificial intelligence's ability to identify wildlife species in photos ...

Alzamend Neuro tackles Alzheimer's, BD, MDD and PTSD with breakthrough therapies. <li /> AL001 delivers improved brain targeting and fewe ...

Explore Allogene's innovative CAR-T therapies targeting cancer & autoimmune diseases. ASCO updates on ALLO-316 could validate ...

Anna’s hummingbirds have evolved to have longer, larger beaks to access backyard feeders in urban areas. It could be a step ...

One of the longstanding challenges in chemical biology has been finding ways to directly observe biological processes at work ...

Dr. Jitendra Singh described the joint meeting as a breakthrough step in advancing “Ease of Research” by promoting “Ease of ...

Researchers found that peri-coronary adipose tissue attenuation (PCAT), a marker of coronary inflammation, is independently ...